Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
Xconomy
OCTOBER 22, 2018
San Diego-based Qpex has raised $33 million to advance The Medicines Company’s (NASDAQ: MDCO ) old preclinical compounds toward human testing. The Medicines Company exited the infectious disease business last year when it sold three bacteria-fighting products to Melinta Therapeutics.
Let's personalize your content